title: IP-10 serum levels are not increased in mild cognitive impairment and Alzheimer's disease.
authors: D
authors: D
authors: Galimberti
authors: E
authors: E
authors: Venturelli
authors: C
authors: C
authors: Fenoglio
authors: C
authors: C
authors: Lovati
authors: I
authors: I
authors: Guidi
authors: D
authors: D
authors: Scalabrini
authors: C
authors: C
authors: Mariani
authors: N
authors: N
authors: Bresolin
authors: E
authors: E
authors: Scarpini
mesh_terms: D000367:Age Factors; D000368:Aged; D000544:Alzheimer Disease / Q000097:blood* / Q000235:genetics; D053327:Apolipoprotein E4 / Q000235:genetics; D054357:Chemokine CXCL10 / Q000097:blood; D003072:Cognition Disorders / Q000097:blood* / Q000235:genetics; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009483:Neuropsychological Tests
chemical_list: D053327:Apolipoprotein E4; C114753:CXCL10 protein, human; D054357:Chemokine CXCL10